{"name":"Fusion Pharma LLC","slug":"fusion-pharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOQ0tzaUp4SkwzNl91WjNEaFBqeHBwamdwRUVXa1dYZEZ1QkNwdVVfSXQwQnNnd2tCYmFWTVJLaHZlWEFNTFZtaHFKRWU4LW4xQXFtNkFPMmFIeFNIdDhKVkE3cDdvZU1mbm84Sm5vYzJwNTJEdWRLZDAzY1JPbUstR0w5enV2MURuZWV2Tmo3b1lyVjNTU1g2U0RHUEJ0QlVRVElTN1NwanEwaVQyTXZ5T1FUaUhRSUJaWWJ4VTZLbHNIekdfeFBJM29R?oc=5","date":"2026-01-05","type":"pipeline","source":"BioSpace","summary":"SHINE Completes Acquisition of Lantheus SPECT Business, Names Michael Rossi SHINE SPECT CEO - BioSpace","headline":"SHINE Completes Acquisition of Lantheus SPECT Business, Names Michael Rossi SHINE SPECT CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNNDBSYVA0eUtMbDlRc3FIeFNkVlBkMTE5c19aNzBVN3psaTE0M195Z29vaWRwd0dZVUFxY2E2X2pVWmZpNERqMlZiaXpKRm52VmthZmVtbEx4bExuTXkzc2ZOLXZiTHJBekVxYUhnMHhiNTh6LUlVT2lqUzJqMEJGWVRBd0FDQ1UxSVNieGdpZUFZMFExbWdGNzhGMXNlX1VvNmVJZkdSNk5DTWd5ZmttNA?oc=5","date":"2025-12-23","type":"deal","source":"Fierce Pharma","summary":"AstraZeneca, betting on radiopharmaceuticals, extends Niowave isotope supply deal by 10 years - Fierce Pharma","headline":"AstraZeneca, betting on radiopharmaceuticals, extends Niowave isotope supply deal by 10 years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxPX0UzOHhYQjFkTk42ajlBNzBod2Zkb0V1eVhuTGl5SndXVlJmLTlaYXZvOGdsTUxKN0VYQmowZEZDa3hIS3hWSENlNmdVQUhUbDBTZ2NpaDNiMGhSWHhwY3diWUtTem1RYlVObG1sbWtQVWg0eEZnSEoyeE9sUjBtZndBWWktWjlEblBvQ2ZLRDBjc080UkNyb1Njb1ZEaGZLMFNZajMxOVd6elFKSnlOYk5VZWpaOEN6S2JpVE9NWXhPU0FkWUFNN014SWh3QWJuaV9hbHdQZ1NjWDBYZEVWamhzdnktNERsN0dBOWdtcTVNanJEaWdkMWQ3SVk5MEtlM3RfQURwMUx1dXZzSllHWTFCY3ExSUJQVkI1OU0zWQ?oc=5","date":"2025-11-20","type":"deal","source":"Business Wire","summary":"Shore Capital Partners Announces the Merger of Reliant Healthcare and Care Fusion Rx to Form a Leading National Infusion Therapy Platform - Business Wire","headline":"Shore Capital Partners Announces the Merger of Reliant Healthcare and Care Fusion Rx to Form a Leading National Infusion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOWFRlejROWk1ZTzF0cFk5OF81Nk5WcFNaNFR2NzBqbnlsazI4RTlHMkx1THNCZFVvMVNuamZ3b0Y0SVJ0UG5HT3B1QnFJQmR5ekRwVmlxaHg4MEI5WFRQaGhrcFN3aVo3ZDlPU2lzRFR1TFdNajBBSC14LUowd0FkNEN4d0JVd3FpSUd5WlhPaGtDTHUyRVdNeUh5Yw?oc=5","date":"2025-09-26","type":"pipeline","source":"Fierce Biotech","summary":"Merck KGaA picks new pilot for turbulent times—Chutes & Ladders - Fierce Biotech","headline":"Merck KGaA picks new pilot for turbulent times—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOYmZuZG5OTkktN2dRdy1BNGlOMHBNdHE5b3RybzZWX2c4YWNkMDRVYVZkMzdDa0NjeDJ2WTVpcGRsRExNNkg3a1Y3N04xSnlLLUVlRVdhU244QjBXb0RXb3paN0xEMGVNRTBmb1o3S1RqeFZaaXcxZkx1WFJ0S19NOWMtT05RTUlNdUJyRlRfcWxXRHp0Q2hZTm1VZTBvQQ?oc=5","date":"2024-06-04","type":"pipeline","source":"AstraZeneca","summary":"Acquisition of Fusion completed - AstraZeneca","headline":"Acquisition of Fusion completed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQQUcyR1dZVTd2cXcxX0RSX0tMWDJGTDZ5NXROOGdZalVteU9zSGhHaG5sZWhTcTZTTU83ZEMxOWNVYllZMWpoX3BHc2VFOFpVRGRwQU5zeHJUbE9jTlJIMW05czBPSXV6N0JkN20wdkc1UTVXeVZuTDRmT3ktaGhzMVdoWXpKZjZZTHlfX3V3NGhXV2RWVmJLSnJSZUhGbHB5bXFvdWNB?oc=5","date":"2024-06-04","type":"pipeline","source":"PR Newswire","summary":"Acquisition of Fusion Pharmaceuticals Completed - PR Newswire","headline":"Acquisition of Fusion Pharmaceuticals Completed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPSzB5Qm54ekVNWDRNUUFkYTUwUnJOVDRnTm1KeDhkbGNDb2pveHFfRzVaeVJYMHNqOUNpSDdGRFZub1F3enlfVWNkekNtbEZSQjB6TVhMTzlqQ0ItSmxYNmc0S0FLdDFacTJWMnM2YmQxVm1nenVpS1dpTHZIRFJHWDIxVWw0WWlVRnZ4eElXZW05RkdCaEE1MG9hbk1OQ0x1d3dMYWVn?oc=5","date":"2024-03-20","type":"deal","source":"Investor's Business Daily","summary":"Radiopharma Space Heats Up As Biotech Rockets 99% on $2 Billion Deal - Investor's Business Daily","headline":"Radiopharma Space Heats Up As Biotech Rockets 99% on $2 Billion Deal - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-03-19","type":"pipeline","source":"cnbc.com","summary":"AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase - cnbc.com","headline":"AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPVkdCc3A4dXdfMncwa1BKMW96dHpwTFNhdVp3d0lSejlQejF4TFd4TFl6cFhxb0JxWXE4V3dCZVZhMXpiQ0l0VlNzd2FPMW9nLUtHRGhZb2xJUlBPYk5vNHptQWVRNC03cEVQMUxVR3JhR3RuWFJpeEk1dE16R1RMd0RxUl91OTF5RHFtMVlMeHZRV0pWaFE?oc=5","date":"2024-03-19","type":"deal","source":"citybiz","summary":"Fusion Pharmaceuticals to be Acquired by AstraZeneca - citybiz","headline":"Fusion Pharmaceuticals to be Acquired by AstraZeneca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQQ2pCZmhpYi1xYVd4bzIxMDZrRWltWEEyejRLdUdLR1lmVVc5U05nTk92UFM1ZUM4WnhpbFRaVDBYaUhxTktXREU4ekRFdFNFeEVnX1pEY0FSdXVmNTg4RlFQRHowTDVGT3QteW1jZG1UOGc4YUVMbmE3bmlZYXNqcVl5eW8weDVJYkJhTkhOSWtxU0o1eE1YQnhCRXBQcVJqa3NDTWRkTlZlYnFCZEIzNTk4Y3FabVhMV1JtQjhYZUpUTjVxWWo4Vk8teUlzN3Q5azNvNGJjSjVWM1pZdF9MbTgxU2t0WGRvWXlWLVR0cm5OT1QxalpMdmJsOW1zNktRX254aF9Gb0dkRXR3RTFvUlRn?oc=5","date":"2024-03-19","type":"deal","source":"PR Newswire","summary":"Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer - PR Newswire","headline":"Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Tre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQTVd2a2hRRWhHU0dMNEFQMlM4TUR2Yl9LQlVEM2lvSXg5Umc1SlQ5cjNZczlKX0hHQktaLVF2eEVRbElBQUp4ZjhBWFduYnhsMjBsTXBPcUp5dG05UzR4MlJyZTBpYVkzOHViblJPVFYxNkhsSG53bDI2VEU3aXpYSTJBbkNwM0pQQlU5X1VBWER0enlFRTJlM29LUQ?oc=5","date":"2024-03-19","type":"deal","source":"AstraZeneca","summary":"AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer - AstraZeneca","headline":"AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNOVQ1M3V0ekxQNzBBRmg5RGxhVE1YSml4SmZlTGJKeFB2VUJVOVdpQWc2NHRiMmMxUHdObWJJOUxnbXdJc2dUMGtpb2trXzEtNV8tV2MxTDc0OFF2azFSaVhCTUd6ZmlheGZ2cF9yUklqbW5neWVTZFpHNjZia25CT19JTy1ndmlzVTdGaEw0Vm5VQkpXeU40MW1FcnBxVHAxMTNSSXFyWVVVYjdCM1h4TE83ZllfZUtqZTA4cy1ndVp0ZjRtVlJlanV2dw?oc=5","date":"2020-06-22","type":"pipeline","source":"renaissancecapital.com","summary":"FUSN IPO News - Solid tumor biotech Fusion Pharmaceuticals sets terms for $125 million IPO - renaissancecapital.com","headline":"FUSN IPO News - Solid tumor biotech Fusion Pharmaceuticals sets terms for $125 million IPO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}